In accordance with its p53 activating role, it has been proposed that p38MAPK activation could act as an oncosuppressive pathway; however, evidence also suggests that p38MAPK signaling is highly active in different types of cancers, favoring tumor growth [2,9,10,11]. Here, TP53 is linked to cancer.